Cargando…
Modulation by decitabine of gene expression and growth of osteosarcoma U2OS cells in vitro and in xenografts: Identification of apoptotic genes as targets for demethylation
BACKGROUND: Methylation-mediated silencing of genes is one epigenetic mechanism implicated in cancer. Studies regarding the role of modulation of gene expression utilizing inhibitors of DNA methylation, such as decitabine, in osteosarcoma (OS) have been limited. A biological understanding of the ove...
Autores principales: | Al-Romaih, Khaldoun, Somers, Gino R, Bayani, Jane, Hughes, Simon, Prasad, Mona, Cutz, Jean-Claude, Xue, Hui, Zielenska, Maria, Wang, Yuzhuo, Squire, Jeremy A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034371/ https://www.ncbi.nlm.nih.gov/pubmed/17845729 http://dx.doi.org/10.1186/1475-2867-7-14 |
Ejemplares similares
-
In Vitro Analysis of Integrated Global High-Resolution DNA Methylation Profiling with Genomic Imbalance and Gene Expression in Osteosarcoma
por: Sadikovic, Bekim, et al.
Publicado: (2008) -
The Genetics of Osteosarcoma
por: Martin, Jeff W., et al.
Publicado: (2012) -
Cause and Consequences of Genetic and Epigenetic Alterations in Human Cancer
por: Sadikovic, B, et al.
Publicado: (2008) -
Epigenetic alteration by DNA-demethylating treatment restores apoptotic response to glucocorticoids in dexamethasone-resistant human malignant lymphoid cells
por: Miller, Aaron L, et al.
Publicado: (2014) -
ALKBH5-mediated m(6)A demethylation of lncRNA PVT1 plays an oncogenic role in osteosarcoma
por: Chen, Shuo, et al.
Publicado: (2020)